Corrigendum to: Heparanase released from mesenchymal stem cells activates integrin beta1/HIF-2alpha/Flk-1 signaling and promotes endothelial cell migration and angiogenesis: Heparanase-Induced Migration and Angiogenesis (STEM CELLS, (2015), 33, 6, (1850-1862), 10.1002/stem.1995);Heparanase released from mesenchymal stem cells activates integrin beta1/HIF-2alpha/Flk-1 signaling and promotes endothelial cell migration and angiogenesis

Stem Cells

Volumn 33, Issue 6, 2015, Pages 1850-1862

  Hu, Xinyang ^a,b   Zhang, Ling ^a,b   Jin, Jing ^a,b   Zhu, Wei ^a,b   Xu, Yinchuan ^a,b   Wu, Yan ^a,b   Wang, Yingchao ^a,b   Chen, Han ^a,b   Webster, Keith A ^c   Chen, Huiqiang ^a,b   Yu, Hong ^a,b   Wang, Jian'an ^a,b  

^a ZHEJIANG UNIVERSITY   (China)

^b Provincial Key Laboratory of Cardiovascular Research of Zhejiang Province   (China)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Angiogenesis; Heparanase; Mesenchymal stem cell

Indexed keywords

BETA1 INTEGRIN; HEPARANASE; HYPOXIA INDUCIBLE FACTOR 2ALPHA; PLATELET DERIVED GROWTH FACTOR BB; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; BETA GLUCURONIDASE; ENDOTHELIAL PAS DOMAIN-CONTAINING PROTEIN 1; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ARTICLE; BLOOD FLOW; CELL CULTURE; CELL MIGRATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HYPOXIA; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LENTIVIRINAE; MESENCHYMAL STEM CELL; SIGNAL TRANSDUCTION; UMBILICAL VEIN ENDOTHELIAL CELL; WESTERN BLOTTING; ANIMAL; BONE MARROW CELL; CELL MOTION; CYTOLOGY; MESENCHYMAL STROMA CELL; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PHYSIOLOGY; SPRAGUE DAWLEY RAT;

RATTUS;

ANIMALS; ANTIGENS, CD29; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BONE MARROW CELLS; CELL MOVEMENT; CELLS, CULTURED; GLUCURONIDASE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MESENCHYMAL STROMAL CELLS; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84929733248     PISSN: 10665099     EISSN: 15494918     Source Type: Journal    
DOI: 10.1002/stem.3019     Document Type: Erratum

References (40)

1. Heil M, Schaper W,. Insights into pathways of arteriogenesis. Curr Pharm Biotechnol 2007; 8: 35-42.
2. Koneru S, Varma Penumathsa S, Thirunavukkarasu M, et al., Sildenafil-mediated neovascularization and protection against myocardial ischaemia reperfusion injury in rats: Role of VEGF/angiopoietin-1. J Cell Mol Med 2008; 12: 2651-2664.
3. Liang H, Hou H, Yi W, et al., Increased expression of pigment epithelium-derived factor in aged mesenchymal stem cells impairs their therapeutic efficacy for attenuating myocardial infarction injury. Eur Heart J 2013; 34: 1681-1690.
4. Poitevin S, Cussac D, Leroyer AS, et al., Sphingosine kinase 1 expressed by endothelial colony-forming cells has a critical role in their revascularization activity. Cardiovasc Res 2014; 103: 121-130.
5. Chamberlain G, Fox J, Ashton B, et al., Concise review: Mesenchymal stem cells: Their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 2007; 25: 2739-2749.
6. Pisano C, Vlodavsky I, Ilan N, et al., The potential of heparanase as a therapeutic target in cancer. Biochem Pharmacol 2014; 89: 12-19.
7. Lever R, Rose MJ, McKenzie EA, et al., Heparanase induces inflammatory cell recruitment in vivo by promoting adhesion to vascular endothelium. Am J Physiol Cell Physiol 2014; 306: C1184-1190.
8. Fux L, Ilan N, Sanderson RD, et al., Heparanase: Busy at the cell surface. Trends Biochem Sci 2009; 34: 511-519.
9. Purushothaman A, Hurst DR, Pisano C, et al., Heparanase-mediated loss of nuclear syndecan-1 enhances histone acetyltransferase (HAT) activity to promote expression of genes that drive an aggressive tumor phenotype. J Biol Chem 2011; 286: 30377-30383.
10. Gingis-Velitski S, Zetser A, Flugelman MY, et al., Heparanase induces endothelial cell migration via protein kinase B/Akt activation. J Biol Chem 2004; 279: 23536-23541.
11. Zetser A, Bashenko Y, Edovitsky E, et al., Heparanase induces vascular endothelial growth factor expression: Correlation with p38 phosphorylation levels and Src activation. Cancer Res 2006; 66: 1455-1463.
12. Hu X, Yu SP, Fraser JL, et al., Transplantation of Hypoxia-preconditioned mesenchymal stem cells improves infracted heart function via enhanced survival of implanted cells and angiogenesis. J Thorac Cardiovasc Surg 2008; 135: 799-808.
13. Uemura R, Xu M, Ahmad N,. Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling. Circ Res 2006; 98: 1414-1421.
14. Chen HQ, Liu XB, Zhu W, et al., SIRT1 ameliorates age-related senescence of mesenchymal stem cells via modulating telomere shelterin. Front Aging Neurosci 2014; 6: 103.
15. Limbourg A, Korff T, Napp LC, et al., Evaluation of postnatal arteriogenesis and angiogenesis in a mouse model of hind-limb ischemia. Nat Protoc 2009; 4: 1737-1746.
16. Aicher A, Heeschen C, Sasaki K, et al., Low-energy shock wave for enhancing recruitment of endothelial progenitor cells: A new modality to increase efficacy of cell therapy in chronic hind limb ischemia. Circulation 2006; 114: 2823-2830.
17. Redmond EM, Cahill PA, Hirsch M, et al., Effect of pulse pressure on vascular smooth muscle cell migration: The role of urokinase and matrix metalloproteinase. Thromb Haemost 1999; 81: 293-300.
18. Xu H, Czerwinski P, Hortmann M, et al., Protein kinase C α promotes angiogenic activity of human endothelial cells via induction of vascular endothelial growth factor. Cardiovasc Res 2008; 78: 349-355.
19. Kim J, Kwak HJ, Cha JY, et al., The role of prolyl hydroxylase domain protein (PHD) during rosiglitazone-induced adipocyte differentiation. J Biol Chem 2014; 289: 2755-2764.
20. Han Y, Yang K, Proweller A, et al., Inhibition of ARNT severely compromises endothelial cell viability and function in response to moderate hypoxia. Angiogenesis 2012; 15: 409-420.
21. Kim HY, Yang DH, Shin SW, et al., CXXC5 is a transcriptional activator of Flk-1 and mediates bone morphogenic protein-induced endothelial cell differentiation and vessel formation. FASEB J 2014; 28: 615-626.
22. Hedges JC, Dechert MA, Yamboliev IA, et al., A Role for p38MAPK/HSP27 pathway in smooth muscle cell migration. J Biol Chem 1999; 274: 24211-24219.
23. Evans IM, Britton G, Zachary IC,. Vascular endothelial growth factor induces heat shock protein (HSP) 27 serine 82 phosphorylation and endothelial tubulogenesis via protein kinase D and independent of p38 kinase. Cell Signal 2008; 20: 1375-1384.
24. Wu S, Wu X, Zhu W, et al., Immunohistochemical study of the growth factors, aFGF, bFGF, PDGF-AB, VEGF-A and its receptor (Flk-1) during arteriogenesis. Mol Cell Biochem 2010; 343: 223-229.
25. Scott A, Mellor H,. VEGF receptor trafficking in angiogenesis. Biochem Soc Trans 2009; 37: 1184-1188.
26. Fang HY, Hughes R, Murdoch C, et al., Hypoxia-inducible factors 1 and 2 are important transcriptional effectors in primary macrophages experiencing hypoxia. Blood 2009; 114: 844-859.
27. Ridgway LD, Wetzel MD, Ngo JA, et al., heparanse-induced GEF-H1 signaling regulates the cytoskeletal dynamics of brain metastatic breast cancer cells. Mol Cancer Res 2012; 10: 689-702.
28. Zetser A, Bashenko Y, Miao HQ, et al., Heparanase affects adhesive and tumorigenic potential of human glioma cells. Cancer Res 2003; 63: 7733-7741.
29. Li Y, Liu H, Huang YY, et al., Suppression of endoplasmic reticulum stress-induced invasion and migration of breast cancer cells through the downregulation of heparanase. Int J Mol Med 2013; 31: 1234-1242.
30. Liew A, O'Brien T,. Therapeutic potential for mesenchymal stem cell transplantation in critical limb ischemia. Stem Cell Res Ther 2012; 3: 28.
31. Roy M, Marchetti D,. Cell surface heparan sulfate released by heparanase promotes melanoma cell migration and angiogenesis. J Cell Biochem 2009; 106: 200-209.
32. Yamashita J, Itoh H, Hirashima M, et al., Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature 2000; 408: 92-96.
33. Wurmser A E, Nakashima K, Summers RG, et al., Cell fusion-independent differentiation of neural stem cells to the endothelial lineage. Nature 2004; 430: 350-356.
34. Francescone R, Scully S, Bentley B, et al., Glioblastoma-derived tumor cells induce vasculogenic mimicry through Flk-1 protein activation. J Biol Chem 2012; 287: 24821-24831.
35. Lee K, Qian DZ, Rey S, et al., Anthracycline chemotherapy inhibits HIF-1 transcriptional activity and tumor-induced mobilization of circulating angiogenic cells. Proc Natl Acad Sci USA 2009; 106: 2353-2358.
36. Ben-Shoshan J, Schwartz S, Luboshits G, et al., constitutive expression of HIF-1α and HIF2α in bone marrow stromal cells differentially promotes their proangiogenic proterties. Stem Cells 2008; 26: 2634-2643.
37. Elvert G, Kappel A, Heidenreich R, et al., cooperative interaction of hypoxia-inducible factor-2α and Ets-1 in the transcriptional activation of vascular endothelial growth factor receptor-2 (Flk-1). J Biol Chem 2003; 278: 7520-7530.
38. Wada T, Shimba S, Tezuka M,. transcriptional regulation of the hypoxia inducible factor-2alpha gene during adipose differentiation in 3T3-L1 cells. Biol Pharm Bull 2006; 29: 49-54.
39. Chang LH, Pan SL, Lai CY, et al., Activated PAR-2 regulates pancreatic cancer progression through ILK/HIF-α-Induced TGF-a expression and MEK/VEGF-A-mediated angiogenesis. Am J Pathol 2013; 183: 566-575.
40. Keely S, Glover LE, MacManus CF, et al., Selective induction of integrin beta1 by hypoxia-inducible factor: Implications for wound healing. FASEB J 2009; 23: 1338-1346.